Browsing by Author "Semir, Vranic"
Now showing items 1-3 of 3
-
Comment on the manuscript “Histological subtype is associated with PD-L1 expression and CD8+ T-cell infiltrates in triple-negative breast carcinoma” by Salisbury et al. (Ann Diagn Pathol 2022; 57: 151901, https://doi.org/10.1016/j.anndiagpath.2022.151901)
Semir, Vranic ( Elsevier , 2022 , Other)I read with great interest a recent paper written by Salisbury et al. published in the April 2022 issue of the Annals of Diagnostic Pathology [1]. In their study, the authors explored a small cohort of triple-negative ... -
Molecular profiling of the metaplastic spindle cell carcinoma of the breast reveals potentially targetable biomarkers
Semir, Vranic; Stafford, Phillip; Palazzo, Juan; Skenderi, Faruk; Swensen, Jeffrey; Xiu, Joanne; Spetzler, David; Gatalica, Zoran... more authors ... less authors ( Elsevier , 2020 , Article)IntroductionSpindle cell carcinoma is a rare subtype of metaplastic breast cancer (MBC), with triple-negative (TNBC: ER-/PR-/Her2-) phenotype. It is associated with a marked resistance to conventional chemotherapy and has ... -
An Update on the Molecular and Clinical Characteristics of Apocrine Carcinoma of the Breast
Semir, Vranic; Gatalica, Zoran ( Elsevier , 2021 , Article)Apocrine carcinoma of the breast is a rare malignancy. According to 2019 WHO classification, apocrine cellular features and a characteristic steroid receptor profile (Estrogen receptor (ER)-negative and androgen receptor ...